ESR2 and urinary bladder carcinoma: Interestingly, in bladder cancer, reports have suggested that ERβ could play positive roles in promoting bladder cancer progression and sh‐ERβ or an ERβ antagonist could inhibit bladder cancer growth (Hsu et al., 2014).